Turnstone Biologics Corp (TSBX) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti

GURU.Markets platformasidagi Turnstone Biologics (TSBX) narxlar tarixi, u yerda ko'rsatkich -0.20 darajasida turibdi, TIL terapiyasining samaradorligi va shaxsiylashtirilgan dori vositalarining ishlab chiqarish sur'atlari bilan korrelyatsiyaga ega. Kompaniyaning AQSh markazlari onkolitik viruslarni ishlab chiqadi va o'smalarga qarshi kurashishning innovatsion usullarini sinovdan o'tkazadi. Global bozorlardan mustaqilligi va sog'liqni saqlashga doimiy talab tufayli Turnstone Biologics (TSBX) ishonchli himoya aktiviga xizmat qiladi.

TSBX turnstonebio.com: Narx-foyda koeffitsiyenti 23.03.2024 - 24.08.2025 oraligʻida

Turnstone Biologics kompaniyasining tahliliy kesimlari

Kompaniyaning har tomonlama tahlili:TSBX turnstonebio.com

P/E hisob-kitob modeli operatsion xarajatlar va foyda kapitalizatsiyasi stavkalariga nisbatan juda sezgir hisoblanadi. Ushbu metrika sof daromadning bitta birligining bozor qiymatini aks ettirib, kapitalning muzlatilishi yoki yashirin soliq imtiyozlari xatarlarini ochib beradi. Turnstone Biologics (TSBX) uchun ushbu muvozanat terapiya ishlab chiqish xarajatlarini kamaytiradigan TIL laboratoriyalarining avtomatlashtirilishiga bog'liq. Robotlashtirish samaradorligi yakuniy koeffitsiyentni bevosita sozlaydi. Turnstone Biologics (TSBX) ning nisbiy P/E baholashi ushbu fundamental dinamikani aniq namoyish etadi.

Raqobatdosh kompaniyalar

Kapitalizatsiyaning foydaga nisbati immunitybio.com IBRX|P/E multiplikatori IMCR|Janux Therapeutics Inc (JANX) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Arcus Bio - Narx-foyda koeffitsiyenti|Zymeworks Biopharmaceuticals (ZYME) - Kapitalizatsiyaning foydaga nisbati|TNGX: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati IOVA (iovance.com)|IMTX: P/E multiplikatori|XNCR - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Compass Bio|Narx-foyda koeffitsiyenti Replimune Inc. (REPL)|Narxning foydaga nisbati Lyell Immunopharma (LYEL)|Narx-foyda koeffitsiyenti innate-pharma.com IPHA|Pyxis Oncology - Narx-foyda koeffitsiyenti|P/E multiplikatori Compugen Ltd CGEN|IOBT - Narxning foydaga nisbati|STRO (Sutro Biopharma, Inc) - Narx-foyda multiplikatori|MiNK Therapeutics, Inc. (INKT) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Werewolf Therapeutics, Inc. (HOWL)|Narx-foyda koeffitsiyenti IMMX|ALXO - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narx-foyda koeffitsiyenti CUE (Cue Biopharma, Inc.)|Bozor narxining sof foydaga nisbati PDSB|P/E multiplikatori SONN (Sonnet BioTherapeutics Holdings)|Kompaniya qiymatining sof foydaga nisbati MAIA|Liminatus Pharma LLC - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati LAVA Therapeutics N.V.|NextCure Corp (NXTC) - Narxning foydaga nisbati|Leap Therapeutics - Kompaniya qiymatining sof foydaga nisbati|INTS (Intensity Therapeutics Inc) - P/E multiplikatori|P/E multiplikatori Sensei Bio|Narxning foydaga nisbati Theriva Biologics (TOVX)|GRTS: Kapitalizatsiyaning sof foydaga nisbati|Kineta Bio - Narx-foyda koeffitsiyenti|NexImmune Corporation (NEXI) - Kapitalizatsiyaning foydaga nisbati|VCNX: Narx-foyda koeffitsiyenti|harpoontx.com - Bozor narxining sof foydaga nisbati